Induced Pluripotent Stem Cells Forming an Emerging Market

WELLESLEY, Mass.-June 16, 2020- (

The global market for induced pluripotent stem cells (iPSCs), should reach $3.8 billion, growing 9.2% annually, according to the latest report by BCC Research, Induced Pluripotent Stem Cells: Global Markets.

iPSCs are reprogrammed cells from a patients body and are not harvested from embryos, thus avoiding the ethical debates associated with embryonic stem cells. Like other stem cells, they hold the immense promise of transforming into various types of human tissue cells and potentially representing highly effective treatments for serious illnesses.

Report Highlights

Read the full report here:

As a breakthrough technology recognized by the Nobel Prize in Physiology or Medicine 2012, iPSCstechnology has brought a revolutionary change to modern medicine, write BCC Research analysts. iPSC-related products are forming an emerging market despite the fact that clinical applications are still at their early stage. The potential scope of the iPSC market is becoming clear.

About BCC ResearchBCC Research publishes market research reports that provide organizations with intelligence to drive smart business decisions. By partnering with industry experts worldwide, BCC Research provides unbiased measurements and assessments of global markets covering current and emerging industrial and technology sectors. For more information about BCC Research, visit

Press Release

Original Source:Stem Cells Without Ethical Implications Are Ready for the Spotlight

Read more:

Stem Cells Without Ethical Implications Are Ready for the Spotlight - Press Release - Digital Journal

Related Post

Leave a comment

Your email address will not be published. Required fields are marked *